Related Experiment Videos
The eotaxins in asthma and allergic inflammation: implications for therapy
1Department of Respiratory, Medicine and Allergy, Guy's, King's and St Thomas' School of Medicine, 5th Floor Thomas Guy House, Guy's Hospital, London, SE1 9RT, UK. chris.corrigan@kcl.ac.uk
Current Opinion in Investigational Drugs (London, England : 2000)
|March 16, 2001
Summary
CC chemokines, especially eotaxins, are increasingly recognized for their role in asthma and allergic inflammation. New therapeutic strategies are being developed based on this emerging evidence.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- Asthma and allergic inflammation involve complex immune responses.
- CC chemokines are signaling proteins that regulate immune cell migration.
- Eotaxins represent a specific subclass of CC chemokines implicated in allergic diseases.
Purpose of the Study:
- To review the current evidence linking CC chemokines, specifically eotaxins, to the pathogenesis of asthma and allergic inflammation.
- To explore novel therapeutic avenues arising from this understanding.
Main Methods:
- Literature review of existing research on CC chemokines and allergic inflammation.
- Analysis of studies investigating the role of eotaxins in disease models.
- Synthesis of findings to identify therapeutic targets.
Main Results:
- Growing evidence supports the significant involvement of CC chemokines, particularly eotaxins, in the development of asthmatic and allergic inflammation.
- Eotaxins are key mediators attracting eosinophils and other inflammatory cells to the airways.
Conclusions:
- CC chemokines, notably eotaxins, are critical players in the pathophysiology of asthma and allergic conditions.
- Targeting CC chemokine pathways presents a promising strategy for developing new anti-inflammatory therapies for allergic diseases.